Syncom Formulations (India) Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹135.41 crore, reflecting a quarter-on-quarter *(QoQ) increase of 17.60 per cent from ₹115.14 crore. This corresponds to a year-on-year *(YoY) decline of 9.05 per cent.
Operating Profit
Operating Profit stands at ₹22.01 crore, reflecting a quarter-on-quarter *(QoQ) increase of 3.77 per cent from ₹21.21 crore. This corresponds to a year-on-year *(YoY) growth of 23.93 per cent.
PBDT
PBDT stands at ₹36.18 crore, reflecting a quarter-on-quarter *(QoQ) increase of 36.79 per cent from ₹26.45 crore. This corresponds to a year-on-year *(YoY) growth of 47.13 per cent.
Profit Before Tax
Profit Before Tax stands at ₹33.70 crore, reflecting a quarter-on-quarter *(QoQ) increase of 34.32 per cent from ₹25.09 crore. This corresponds to a year-on-year *(YoY) growth of 44.64 per cent.
Net Profit
Net Profit stands at ₹25.17 crore, reflecting a quarter-on-quarter *(QoQ) increase of 33.10 per cent from ₹18.91 crore. This represents a 42.28 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Syncom Formulations (India) Ltd Earnings
- YOY
- QOQ
Syncom Formulations (India) Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Syncom Formulations (India) Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Syncom Formulations (India) Ltd Financial Reports
Syncom Formulations (India) Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Syncom Formul. | -0.07% | -3.45% | -2.44% | 24.38% | -5.48% | -26.54% |
| Fredun Pharma | 0.37% | 13.18% | 3.59% | 55.35% | 49.48% | 219.73% |
| Jagsonpal Pharma | 0.71% | -0.28% | 1.46% | 16.29% | 6.55% | -2.23% |
| Shukra Pharma. | -2.04% | -2.55% | 4.31% | -15.10% | -46.09% | 133.23% |
| Lincoln Pharma. | -0.29% | -5.82% | -16.42% | 4.68% | 26.16% | 9.89% |
| Bajaj Healthcare | -1.54% | 4.60% | 2.47% | 2.73% | -25.70% | -40.38% |
| Fermenta Biotec. | 6.20% | 2.89% | 11.75% | -0.19% | -4.81% | 9.45% |
Company Info
Company Information
Chairman & Exec. Director : Kedarmal Bankda
ED / MD / Promoter : Vijay Bankda
Independent Non Exe. Director : Ruchi Jindal
Independent Non Exe. Director : Ritesh Kumar Lunkad
Independent Non Exe. Director : Ankit Jain
Chairman / Executive Director / WTD : ANKIT KEDARMAL BANKDA
Company Sec. & Compli. Officer : Vaishali Agrawal